Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors

Life Sciences

Volumn 80, Issue 13, 2007, Pages 1213-1220

  Ishihara, Kenji ^a   Takahashi, Aki ^a   Kaneko, Motoko ^a   Sugeno, Hiroki ^a   Hirasawa, Noriyasu ^a   Hong, JangJa ^a,b,c   Zee, OkPyo ^b   Ohuchi, Kazuo ^a,d  

^a TOHOKU UNIVERSITY   (Japan)

^b Sungkyunkwan University   (South Korea)

^c Sookmyung Women's University   (South Korea)

^d YASUDA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Differentiation; EoL 1 cells; Eosinophils; Histone deacetylase inhibitor

Indexed keywords

APICIDIN; BETA7 INTEGRIN; BUTYRIC ACID; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR3; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; TRICHOSTATIN A;

ACETYLATION; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; EOSINOPHIL; EOSINOPHILIC LEUKEMIA; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROTEIN EXPRESSION;

ACETYLATION; BUTYRATES; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EOSINOPHILS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE DEACETYLASES; HISTONES; HL-60 CELLS; HUMANS; HYDROXAMIC ACIDS; HYPEREOSINOPHILIC SYNDROME; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; PEPTIDES, CYCLIC; PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER;

EID: 33847245318     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.12.016     Document Type: Article

References (38)

1. Agalioti T., Chen G., and Thanos D. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111 (2002) 381-392
2. Baltus B., Buitenhuis M., van Dijk T.B., Vinson C., Raaijmakers J.A., Lammers J.W., Koenderman L., and de Groot R.P. C/EBP regulates the promoter of the eosinophil-derived neurotoxin/RNS2 gene in human eosinophilic cells. Journal of Leukocyte Biology 66 (1999) 683-688
3. Berger S.L. Histone modifications in transcriptional regulation. Current Opinion in Genetics and Development 12 (2002) 142-148
4. Boyes J., Byfield P., Nakatani Y., and Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396 (1998) 594-598
5. Kip1 in maintaining the levels of D-type cyclins in vivo. Biochimica et Biophysica Acta 1691 (2004) 105-116
6. + cells. Blood 101 (2003) 134-142
7. Cools J. FIP1L1-PDGFRα, a therapeutic target for the treatment of chronic eosinophilic leukemia. Verhandelingen - Koninklijke Academie voor Geneeskunde van België 67 (2005) 169-176
8. Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J., Kutok J., Clark J., Galinsky I., Griffin J.D., Cross N.C., Tefferi A., Malone J., Alam R., Schrier S.L., Schmid J., Rose M., Vandenberghe P., Verhoef G., Boogaerts M., Wlodarska I., Kantarjian H., Marynen P., Coutre S.E., Stone R., and Gilliland D.G. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. New England Journal of Medicine 348 (2003) 1201-1214
9. Cools J., Quentmeier H., Huntly B.J., Marynen P., Griffin J.D., Drexler H.G., and Gilliland D.G. The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood 103 (2004) 2802-2805
10. Csordas A. On the biological role of histone acetylation. Biochemical Journal 265 (1990) 23-38
11. Darkin-Rattray S.J., Gurnett A.M., Myers R.W., Dulski P.M., Crumley T.M., Allocco J.J., Cannova C., Meinke P.T., Colletti S.L., Bednarek M.A., Singh S.B., Goetz M.A., Dombrowski A.W., Polishook J.D., and Schmatz D.M. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 13143-13147
12. Du J., Stankiewicz M.J., Liu Y., Xi Q., Schmitz J.E., Lekstrom-Himes J.A., and Ackerman S.J. Novel combinatorial interactions of GATA-1, PU.1, and C/EBPε isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. Journal of Biological Chemistry 277 (2002) 43481-43494
13. Fischkoff S.A., and Condon M.E. Switch in differentiative response to maturation inducers of human promyelocytic leukemia cells by prior exposure to alkaline conditions. Cancer Research 45 (1985) 2065-2069
14. Giembycz M.A., and Lindsay M.A. Pharmacology of the eosinophil. Pharmacological Reviews 51 (1999) 213-340
15. Gombart A.F., Kwok S.H., Anderson K.L., Yamaguchi Y., Torbett B.E., and Koeffler H.P. Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP and PU.1. Blood 101 (2003) 3265-3273
16. Griffin J.H., Leung J., Bruner R.J., Caligiuri M.A., and Briesewitz R. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 7830-7835
17. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 389 (1997) 349-352
18. Gurvich N., Tsygankova O.M., Meinkoth J.L., and Klein P.S. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Research 64 (2004) 1079-1086
19. Hara K., Hasegawa T., Ooi H., Koya T., Tanabe Y., Tsukada H., Igarashi K., Suzuki E., Arakawa M., and Gejyo F. Inhibitory role of eosinophils on cell surface plasmin generation by bronchial epithelial cells: inhibitory effects of transforming growth factor β. Lung 179 (2001) 9-20
20. Hayakawa F., Towatari M., Ozawa Y., Tomita A., Privalsky M.L., and Saito H. Functional regulation of GATA-2 by acetylation. Journal of Leukocyte Biology 75 (2004) 529-540
21. Hirasawa R., Shimizu R., Takahashi S., Osawa M., Takayanagi S., Kato Y., Onodera M., Minegishi N., Yamamoto M., Fukao K., Taniguchi H., Nakauchi H., and Iwama A. Essential and instructive roles of GATA factors in eosinophil development. Journal of Experimental Medicine 195 (2002) 1379-1386
22. Ishihara K., Hong J., Zee O., and Ohuchi K. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils. British Journal of Pharmacology 142 (2004) 1020-1030
23. Ishihara K., Hong J., Zee O., and Ohuchi K. Mechanism of the eosinophilic differentiation of HL-60 clone 15 cells induced by n-butyrate. International Archives of Allergy and Immunology 137 Suppl 1 (2005) 77-82
24. Izumi T., Kishimoto S., Takano T., Nakamura M., Miyabe Y., Nakata M., Sakanaka C., and Shimizu T. Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation. Biochemical Journal 305 (1995) 829-835
25. Johnson D.G., and Walker C.L. Cyclins and cell cycle checkpoints. Annual Review of Pharmacology and Toxicology 39 (1999) 295-312
26. Joo M., Park G.Y., Wright J.G., Blackwell T.S., Atchison M.L., and Christman J.W. Transcriptional regulation of the cyclooxygenase-2 gene in macrophages by PU.1. Journal of Biological Chemistry 279 (2004) 6658-6665
27. Klug A., Rhodes D., Smith J., Finch J.T., and Thomas J.O. A low resolution structure for the histone core of the nucleosome. Nature 287 (1980) 509-516
28. Komatsu Y., Tomizaki K., Tsukamoto M., Kato T., Nishino N., Sato S., Yamori T., Tsuruo T., Furumai R., Yoshida M., Horinouchi S., and Hayashi H. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity. Cancer Research 61 (2001) 4459-4466
29. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes and Development 10 (1996) 142-153
30. KIP1 cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity. Molecular and Cellular Biology 22 (2002) 3014-3023
31. Riggs M.G., Whittaker R., Neumann J.R., and Ingram V.M. n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 268 (1977) 462-464
32. Saito H., Bourinbaiar A., Ginsburg M., Minato K., Ceresi E., Yamada K., Machover D., Breard J., and Mathe G. Establishment and characterization of a new human eosinophilic leukemia cell line. Blood 66 (1985) 1233-1240
33. Saito A., Yamashita T., Mariko Y., Nosaka Y., Tsuchiya K., Ando T., Suzuki T., Tsuruo T., and Nakanishi O. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 4592-4597
34. Sterner D.E., and Berger S.L. Acetylation of histones and transcription-related factors. Microbiology and Molecular Biology Reviews 64 (2000) 435-459
35. Tiffany H.L., Alkhatib G., Combadiere C., Berger E.A., and Murphy P.M. CC chemokine receptors 1 and 3 are differentially regulated by IL-5 during maturation of eosinophilic HL-60 cells. Journal of Immunology 160 (1998) 1385-1392
36. Villar-Garea A., and Esteller M. Histone deacetylase inhibitors: understanding a new wave of anticancer agents. International Journal of Cancer 112 (2004) 171-178
37. Yamaguchi Y., Ackerman S.J., Minegishi N., Takiguchi M., Yamamoto M., and Suda T. Mechanisms of transcription in eosinophils: GATA-1, but not GATA-2, transactivates the promoter of the eosinophil granule major basic protein gene. Blood 91 (1998) 3447-3458
38. Yoshida M., Nomura S., and Beppu T. Effects of trichostatins on differentiation of murine erythroleukemia cells. Cancer Research 47 (1987) 3688-3691